Here we demonstrated that apelin-elicited MSCs autophagy contributed to elevated functional survival of AD-MSCs in ischemic hindlimbs and eventually leaded to enhanced AD-MSCs therapeutic potential in experimental PAD. The gene discussed is APLN; the disease is Alzheimer disease.